AI is moving incredibly fast across the life sciences sector, but many organizations still struggle to build systems that deliver real operational value. In this episode, tech leader Rose LaRocca-Fisch explains why strong data governance and business alignment must come before chasing software trends. Please visit our website to get more information: https://swangroup.net/
Rose shares her practical leadership experience guiding pharmaceutical companies, CDMOs, and global biotech organizations through massive growth. The discussion breaks down why high-profile tech implementations collapse and outlines the exact steps needed to prepare your infrastructure for enterprise-grade tools.
Key themes covered in this conversation:
- Why does advanced software amplify existing operational flaws instead of fixing them
- The OASIS framework for sustainable and scalable IT transformation
- How data readiness directly impacts clinical trial success and manufacturing yields
- Real-world applications using platforms like Databricks to speed up patient enrollment
- The shift toward AI-assisted work and managing data integrity risks
Links from this episode:
- Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
- Get to know more about Rose LaRocca-Fisch: https://www.linkedin.com/in/rose-larocca-fisch
🔔𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐬.
https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1
🔗 Stay Connected With Us.
LinkedIn: https://www.linkedin.com/company/the-swan-group/
Website: https://swangroup.net/
=============================
🎬Suggested videos for you:
▶️ https://www.youtube.com/watch?v=CaHwarSYhrA
▶️ https://www.youtube.com/watch?v=be8szNVFrNk
▶️ https://www.youtube.com/watch?v=_Be6WEEy2JM
▶️ https://www.youtube.com/watch?v=mqpB3pGywkU
▶️ https://www.youtube.com/watch?v=w9QyuG6p3Ys
=============================
#biotechai #pharmatech #lifesciences #datagovernance #clinicaltrials #ittransformation
